MGMT and demyelinating disease of central nervous system: Our study is, therefore, the first to analyze MGMT promoter methylation in a variety of non-neoplastic CNS diseases, and we report cases of variable MGMT hypermethylation in infectious, inflammatory and demyelinating CNS diseases, as well as in those resulting in damage to the myelin sheath.